Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update.
Ocul Immunol Inflamm
; 25(3): 413-417, 2017 Jun.
Article
in En
| MEDLINE
| ID: mdl-27015032
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostheses and Implants
/
Artificial Organs
/
Stevens-Johnson Syndrome
/
Antirheumatic Agents
/
Corneal Diseases
/
Infliximab
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ocul Immunol Inflamm
Journal subject:
ALERGIA E IMUNOLOGIA
/
OFTALMOLOGIA
Year:
2017
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom